Log in to search using one of your social media accounts:


ResApp blames data collection problems for failure of Smartcough-C trial

Brisbane, Australia-based digital health company ResApp has been talking up its Smartcough-C study — a multisite, double-blind study of the company’s smartphone-based respiratory analysis software — for a number of months.
Source: mobihealthnews - Category: Information Technology Source Type: news

Related Links:

More News: Australia Health | Information Technology | Respiratory Medicine | Study